文献速递血液净化与透析慢性肾脏病

血液透析患者瘙痒与临床及患者报告结局的纵向关联

Pruritus in Hemodialysis Patients: Longitudinal Associations With Clinical and Patient-Reported Outcomes.
PubMed 文献 · Am J Kidney Dis · 2023-08-16

在DOPPS 4-6期21国7976例维持性血液透析患者中,约12个月两次评估CKD-aP,51%在任一次评估有中重度瘙痒、22%两次均有。新发瘙痒者抑郁、睡眠不安和疲惫感分别增加13%、10%、14%,缓解者分别下降5%、8%、12%;持续瘙痒者全因死亡、住院和心血管事件风险高于无瘙痒者。

要点

  • 维持性血透患者中约半数在两次评估中至少一次存在中重度CKD-aP,22%持续存在。
  • 新发瘙痒者抑郁、睡眠不安、疲惫感分别增加13%、10%、14%,缓解者分别下降5%、8%、12%。
  • 持续瘙痒者较无瘙痒者全因死亡HR 1.29、住院HR 1.17、心血管事件HR 1.48。

核心结论

  • CKD-aP症状呈慢性,研究结果强调采用标准化方法重复评估该症状的潜在价值。
  • 未来研究应系统探究CKD-aP的潜在病因及有效治疗选择。

研究设计与样本

  • 前瞻性队列研究,纳入DOPPS 4-6期(2009-2018)21个国家7976例维持性血液透析患者,均有两次约间隔12个月的CKD-aP评估。
  • 暴露按初次和约1年后评估分为四组:仅初次有中重度瘙痒(缓解)、仅第二次有(新发)、两次均无(无)、两次均有(持续)。
  • 采用线性混合模型分析1年内实验室值和患者报告结局(PROs)在四组间的变化。

主要发现

  • 51%患者在任一次评估有中重度CKD-aP,22%两次评估均有。
  • 新发瘙痒组抑郁、睡眠不安、疲惫感患病率分别增加13%、10%、14%;缓解组分别下降5%、8%、12%。
  • 无瘙痒组和持续瘙痒组PROs随时间变化极小;两组实验室值(磷、Kt/V)随时间变化未检测到。
  • 与无CKD-aP者相比,持续CKD-aP者调整后全因死亡HR 1.29(95%CI 1.09-1.53)、全因住院HR 1.17(1.07-1.28)、心血管事件HR 1.48(1.26-1.74)。

临床怎么用

  • 对维持性血透患者采用标准化方法重复评估CKD-aP症状。
  • 关注新发瘙痒患者抑郁、睡眠不安和疲惫感的变化。

局限性

  • 两次评估之间未对CKD-aP症状进行 interim 评估。
  • 可能存在选择偏倚:部分患者在第二次评估前死亡或失访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Cross-sectional studies have reported an association of chronic kidney disease-associated pruritus (CKD-aP) with adverse clinical events and patient-reported outcomes (PROs). We studied the longitudinal associations between changes in CKD-aP and clinical outcomes among patients receiving maintenance hemodialysis. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: 7,976 hemodialysis recipients across 21 countries in phases 4-6 (2009-2018) of the Dialysis Outcomes and Practice Patterns Study (DOPPS) who had 2 CKD-aP assessments approximately 12 months apart. EXPOSURES: Exposure status was based on the assessment of pruritis initially and again approximately 1 year later. Four groups were identified, including those with moderate or more severe pruritis only at the initial assessment (resolved), only at the second assessment (incident), at neither assessment (absent), or at both assessments (persistent). OUTCOMES: Laboratory values and PROs ascertained at the initial assessment of pruritis and 1 year later. ANALYTICAL APPROACH: Linear mixed model to investigate changes in laboratory values and PROs over the 1-year study period across the 4 exposure groups. RESULTS: 51% of patients had moderate to severe CKD-aP symptoms at either assessment (22% at both). The prevalences of depression, restless sleep, and feeling drained increased over the study period (+13%,+10%, and+14%, respectively) among patients with incident pruritus and decreased (-5%, -8%, and -12%, respectively) among patients with resolved pruritus. Minimal changes in PROs over time were observed for the absent and persistent groups. Changes over time in laboratory values (phosphorus, Kt/V) were not detected for either of these groups. Compared with patients with absent CKD-aP, the adjusted HRs for patients with persistent CKD-aP were 1.29 (95% CI, 1.09-1.53) for all-cause mortality, 1.17 (1.07-1.28) for all-cause hospitalization, and 1.48 (1.26-1.74) for cardiovascular events. LIMITATIONS: No interim evaluation of CKD-aP symptoms between the 2 assessments; potential selection bias from patients who died or were otherwise lost to follow-up before the second assessment. CONCLUSIONS: CKD-aP symptoms are chronic, and these findings highlight the potential value of repeated assessment of this symptom using standardized approaches. Future research should systematically investigate potential causes of CKD-aP and options for its effective treatment. PLAIN-LANGUAGE SUMMARY: Previous research has studied itching and its consequences in hemodialysis recipients only at a single time point. We surveyed 7,976 patients receiving maintenance hemodialysis to assess itching over a period of 1 year. We found that, among those experiencing itching at the initial assessment, more than half had persistent symptoms 1 year later. Those in whom itching developed during follow-up were more likely to experience depression, poor sleep, long recovery times after dialysis, and feeling faint or drained. These patients also rated their quality of life as poorer than those who did not experience itching. These findings emphasize the potential value of clinical detection of itching and the pursuit of effective treatments for patients receiving dialysis experiencing these symptoms.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Sukul N, Zhao J, Pisoni RL, et al. Pruritus in Hemodialysis Patients: Longitudinal Associations With Clinical and Patient-Reported Outcomes. Am J Kidney Dis. 2023. PMID: 37777951. doi:10.1053/j.ajkd.2023.04.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。